QuidelOrtho (QDEL) Capital Expenditures (2021 - 2026)

QuidelOrtho has disclosed Capital Expenditures across 6 years of filings, most recently posting $25.5 million for Q2 2026.

• In Q2 2026, Capital Expenditures fell 32.0% year-over-year to $25.5 million; the TTM figure through Jun 2026 stood at $154.0 million (down 17.82% YoY), while the FY2025 annual figure was $188.2 million, down 3.54% from the prior year.
• Capital Expenditures came in at $25.5 million for Q2 2026 at QuidelOrtho, down from $34.0 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $66.1 million in Q1 2024 to a low of -$119.5 million in Q1 2023.
• Average Capital Expenditures over 5 years is $34.7 million, with a median of $45.9 million recorded in 2024.
• Year-over-year, Capital Expenditures surged 193.33% in 2023 and tumbled 39.5% in 2026.
• Over 5 years, Capital Expenditures stood at $22.5 million in 2022, then jumped by 116.0% to $48.6 million in 2023, then fell by 2.88% to $47.2 million in 2024, then fell by 4.03% to $45.3 million in 2025, then plunged by 43.71% to $25.5 million in 2026.
• Per Business Quant data, the three most recent Capital Expenditures figures were $25.5 million in Q2 2026, $34.0 million in Q1 2026, and $45.3 million in Q4 2025.